Literature DB >> 25581608

Percutaneous extraction of inadvertently placed left-sided pacemaker leads with complete cerebral embolic protection.

John N Bahadorani1, Amir A Schricker1, Victor G Pretorius1, Ulrika Birgersdotter-Green1, Arturo Dominguez1, Ehtisham Mahmud1.   

Abstract

Lead wire malposition is a known, but rare complication of permanent pacemaker or defibrillator implantation. The actual incidence and prevalence is unknown and management options for inadvertent left ventricular lead malposition have not been uniform. Current recommendations include systemic anticoagulation with warfarin or surgical lead removal with circulatory arrest for compelling clinical scenarios. Percutaneous left-sided lead extraction is contraindicated due to the potentially increased risk of thromboembolic complications associated with this procedure. To our knowledge, this is the first report of percutaneous extraction of inadvertently placed left ventricular and left atrial endocardial pacemaker leads with flow-preserving complete cerebral embolic protection. We also review the current literature regarding the incidence, management, and percutaneous extraction of left-sided cardiac leads.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  cerebral embolic protection; distal embolic protection device; lead wire malposition; percutaneous lead extraction

Mesh:

Year:  2015        PMID: 25581608     DOI: 10.1002/ccd.25826

Source DB:  PubMed          Journal:  Catheter Cardiovasc Interv        ISSN: 1522-1946            Impact factor:   2.692


  2 in total

1.  Chronic lead malposition diagnosis and management: discussion of two cases and literature review.

Authors:  Ahmed Almomani; Amjad Abualsuod; Hakan Paydak; Wilburt Peer; Waddah Maskoun
Journal:  Clin Case Rep       Date:  2017-02-01

2.  Use of a cerebral protection device for the laser extraction of a pacemaker lead traversing a patent foramen ovale.

Authors:  James L Harrison; Rishi Patel; Roy Jogiya; Simon Redwood; Christopher A Rinaldi
Journal:  HeartRhythm Case Rep       Date:  2017-08-24
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.